Good morning, folks. How are you today? A chilly day appears likely here on the Pharmalot corporate campus, where the short people are directing themselves toward the local schoolhouses, the official Pharmalot mascots are fertilizing the weeds and we are brewing that mandatory cup of stimulation. Nothing like a routine. We trust you can relate as a new year of meetings and deadlines beckon. So hoist your own cup, or grab a bottle of water, and let us all get started. Here are a few items to help you along. Have a great day...
Biogen May Spend $299M On Isis Treatment For Kids (Associated Press)
Pfizer Must Pay $45M In Prempro Cases (Bloomberg News)
Arena Resubmits Diet Pill To The FDA (Pharma Times)
Investors Bet Express Scripts-Medco Deal Will Win Approval (Bloomberg News)
Medication Shortages Set A New Record In 2011 (Associated Press)
Allozyne Cuts Workforce After Scrapping Merger Plan (Xconomy)
Shortage Of Guar Gum Thickening Agent Is Seen (InPharma Technologist)
Vernalis Forms Discovery Deal With Roche (Pharma Times)
AstraZeneca Starts Work On New Factory In China (Shanghai Daily)
Regeneron Settles Patent Dispute With Roche Over Eye Drug (Associated Press)
Pfizer Tells India Not To Expand List Of Price Cuts (Business Standard)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr